---
cssClass:
- wide
tags:
  - ðŸ§ª
---

# `Title:` [[TRIKAFTA]]
--- 

- What led me here: [[Corrector Drugs]]

Inlinks
```dataview 
list from [[#this.file.name]] and !outgoing([[# this.file.name]]) 
```
https://www.trikafta.com/how-trikafta-works
## TRIKAFTA

TRIKAFTA, a pharmaceutical product by Vertex Pharmaceuticals, is a novel therapeutic drug used for the treatment of cystic fibrosis (CF). It was designed to target the underlying cause of the disease rather than merely addressing the symptoms. It was approved by the U.S. Food and Drug Administration (FDA) in 2019.

The medicine is composed of three main components - elexacaftor, tezacaftor, and ivacaftor, which work in unison to improve the function of defective CFTR proteins, which are a primary cause of cystic fibrosis.

1. **Elexacaftor:** This component binds to a specific site on the defective CFTR proteins, aiding them in achieving their correct 3D shape, which is vital for their proper functioning.

2. **Tezacaftor:** Similar to elexacaftor, tezacaftor also helps defective CFTR proteins fold properly and reach the cell surface. Together, elexacaftor and tezacaftor help increase the number of functional CFTR proteins on the cell surface.

3. **Ivacaftor:** Ivacaftor works differently from the other two components. Instead of helping the CFTR proteins reach the cell surface, it enhances the performance of the CFTR proteins that are already on the cell surface by helping them stay open for longer. This allows chloride ions to move in and out of the cells more effectively, which is a crucial aspect of normal cell function.

TRIKAFTA is used for treating individuals with cystic fibrosis who have at least one F508del mutation in the CFTR gene, which is estimated to represent 90% of the CF population. Despite the promising lab results, real-world patient experiences may vary, and it is recommended that individuals with cystic fibrosis discuss their treatment options with their healthcare provider.

As of my last training data in September 2021, TRIKAFTA is considered a significant breakthrough in cystic fibrosis treatment. However, it's important to check the most recent scientific literature or regulatory updates for the latest information about its efficacy, side effects, and usage guidelines.